ERBB2 and breast cancer: This analysis revealed low or absent H4K16ac expression in the majority of analyzed BC cases, suggesting that this modification could represent an early sign of BC, moderate or low levels of lysine acetylation or lysine and arginine methylation being detected in basal carcinomas and HER2+ BCs [45].